glp 1 agonists and inflammation GLP-1 in Cardiovascular Diseases: Mechanisms, Clinical Evidence, Emerging Therapies The Impact of GLP-1 Receptor

Non-alcoholic fatty liver disease (NAFLD) can progress to NASH, a major risk factor for liver cancer [95]

They were originally developed to treat type 2 diabetes, which happens when the bodys cells become resistant to the hormone insulin

Rondanelli M, Perna S, Riva A, Petrangolini G, Di Paolo E, Gasparri C

Zeng Q, Xu J, Mu X, et al

References Bodnaruc, A.M., Prudhomme, D., Blanchet, R

GLP-1 Receptor Agonists: Mascots & Mnemonics Jason Cafer MD Oct 17, 2021 10 min read Updated: Jan 29, 2023 Glucagon-like peptide-1 (GLP-1) receptor agonists, the -tides GLP-1 receptor agonists are type 2 diabetes medications, also called GLP analogs or incretin mimetics